RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties

← Drug Reference

Lipid emulsion 20%

Local anesthetic systemic toxicity (LAST) - off-label, guideline-based, Labeled use: parenteral nutrition source of calories/essential fatty acids

Indications

  • Local anesthetic systemic toxicity (LAST) - off-label, guideline-based
  • Labeled use: parenteral nutrition source of calories/essential fatty acids

Adult dosing

  • last bolus over 70kg: dose: 100; unit: mL; route: IV - lipid injectable emulsion 20% (Intralipid 20%, 0.2 g/mL); interval: over 2-3 min; repeat bolus (or double infusion) if still unstable; fixed: true; guideline: ASRA Checklist for Treatment of LAST, 2020 (patients >70 kg); evidence: asra-last
  • last infusion over 70kg: dose: 250; unit: mL; route: IV - lipid injectable emulsion 20% (Intralipid 20%, 0.2 g/mL); interval: over 15-20 min; fixed: true; guideline: ASRA Checklist for Treatment of LAST, 2020 (patients >70 kg); evidence: asra-last

Pediatric dosing

  • last bolus 70kg or less: dose: 1.5; unit: mL/kg; route: IV - lipid injectable emulsion 20% (Intralipid 20%, 0.2 g/mL); interval: over 2-3 min (lean body weight); maximum lipid dose 12 mL/kg total; weightBased: false; pedNote: No label-stated per-dose maximum verified; weight-based calculation disabled. Consult pharmacy/current label.; guideline: ASRA Checklist for Treatment of LAST, 2020 (patients <70 kg); evidence: asra-last
  • last infusion 70kg or less: dose: 0.25; unit: mL/kg/min; route: IV - lipid injectable emulsion 20% (Intralipid 20%, 0.2 g/mL); interval: maximum lipid dose 12 mL/kg total; weightBased: true; maxDose: 0.5; titrationTarget: Titrate to effect: double infusion rate if still unstable (ASRA); guideline: ASRA Checklist for Treatment of LAST, 2020 (patients <70 kg); evidence: asra-last

Renal adjustment

  • Consult pharmacy/current label

Hepatic adjustment

  • Consult pharmacy/current label

Contraindications

  • Known hypersensitivity to egg, soybean, peanut
  • Severe disorders of lipid metabolism (triglyceride > 1,000 mg/dL)

Clinical pearls

  • FDA label is for parenteral nutrition only; LAST dosing below is guideline-based (ASRA 2020), not label-derived
  • Stop or reduce propofol; propofol is not a substitute for 20% lipid emulsion
  • Use 1.2 micron in-line filter for administration.
  • Monitor serum triglycerides and liver function tests regularly.
  • Strictly adhere to the maximum infusion rate (0.75 mL/kg/hour in pediatrics; 0.5 mL/kg/hour in adults).
  • Risk of fat overload syndrome and parenteral nutrition-associated liver disease (PNALD).

Source and review

  • DailyMed label (i.v. fat emulsion, Intralipid), Set ID 48c12fbe-c5e8-a1fc-e063-6294a90a15ae, effective 2026-01-19; ASRA Checklist for Treatment of LAST, 2020 (patients >70 kg); ASRA Checklist for Treatment of LAST, 2020 (patients <70 kg). Last reviewed: 2026-11-11